Neoadjuvant as Future for Drug Development in Breast Cancer--Response
Clin Cancer Res
.
2016 Jan 1;22(1):269.
doi: 10.1158/1078-0432.CCR-15-1643.
Authors
Angela DeMichele
1
,
Douglas Yee
2
,
Melissa Paoloni
3
,
Don Berry
4
,
Laura J Esserman
5
;
I-SPY2 Investigators
Affiliations
1
University of Pennsylvania, Philadelphia, Pennsylvania. angela.demichele@uphs.upenn.edu.
2
University of Minnesota, Minneapolis, Minnesota.
3
QuantumLeap Healthcare Collaborative, San Francisco, California.
4
University of Texas MD Anderson Cancer Center, Houston, Texas.
5
University of California, San Francisco, San Francisco, California.
PMID:
26728411
DOI:
10.1158/1078-0432.CCR-15-1643
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / drug therapy*
Female
Humans
Grants and funding
P30 CA016672/CA/NCI NIH HHS/United States